Mitsubishi Pharma Sign Agreement on 2D Gel Image Analysis
News May 24, 2006
Mitsubishi Pharma Corporation has contracted Ludesi for image analysis of twodimensional protein gels (2D gels), one of the fundamental technologies in proteomics.
"We are proud that Mitsubishi Pharma has selected Ludesi’s technology for 2D gel image analysis, and we look forward to working together in the years to come," commented Ludesi’s CEO Ola Forsstrom-Olsson.
"It is an honor to serve Mitsubishi Pharma’s skilled scientists with top-notch quality in this important proteomics technology."
Experts at Mitsubishi Pharma Corporation tested Ludesi’s system thoroughly and concluded that Ludesi’s offering provided an increased quality and reliability compared to other software systems on the market.